Showing results (151-160 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|March 19, 2017
Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitroKatja Hattar, Christian P Reinert, Ulf Sibelius, et al.Cancer Immunology, Immunotherapy : CII|September 11, 2019
Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironmentSuzanne Ostrand-Rosenberg, Daniel W Beury, Katherine H Parker, et al.Cancer Immunology, Immunotherapy : CII|August 27, 2020
T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancerTakashi Akiyoshi, Osamu Gotoh, Norio Tanaka, et al.Cancer Immunology, Immunotherapy : CII|December 14, 2004
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosityTeresa Rodriguez, Rosa Méndez, Chrissy H Roberts, et al.Cancer Immunology, Immunotherapy : CII|December 14, 2004
Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin productionMakoto Kubo, Takashi Morisaki, Kotaro Matsumoto, et al.Cancer Immunology, Immunotherapy : CII|January 15, 2005
What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumorsS Farzana Hussain, Yvonne PatersonCancer Immunology, Immunotherapy : CII|February 5, 2005
Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemiaM Copland, A R Fraser, S J Harrison, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2005
Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic miceDean Johnston, Jean-Claude BystrynCancer Immunology, Immunotherapy : CII|January 1, 2005
A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumorAxel Bex, Henk Mallo, Martijn Kerst, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2005
Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasmsJürgen Funk, Gabriele Schmitz, Klaus Failing, et al.Pageof 650